Biofilms: an extra hurdle for effective antimicrobial therapy

Area of Science:

• Microbiology
• Infectious Diseases
• Biotechnology

Background:

• Biofilms are microbial communities irreversibly attached to surfaces and embedded in a self-produced matrix.
• These structures protect microbes from external factors like heat, UV radiation, and host immune responses.
• Biofilms are implicated in at least 65% of human bacterial infections, including cystic fibrosis and device-related infections.

Purpose of the Study:

• To review the main characteristics and resistance mechanisms of biofilms.
• To discuss the challenges and pitfalls associated with in vitro biofilm research and modeling.
• To evaluate current anti-biofilm therapies and explore future treatment strategies.

Main Methods:

• Literature review of biofilm characteristics, resistance mechanisms, and in vitro models.
• Analysis of current therapeutic approaches, including antibiotics and biocides.
• Discussion of emerging strategies for anti-biofilm therapies.

Main Results:

• Biofilms exhibit significant resistance to antimicrobial agents, contributing to persistent infections.
• Existing in vitro models have limitations and potential pitfalls that can affect research outcomes.
• No current antimicrobial drug can completely eradicate adherent microbial populations in biofilms.

Conclusions:

• Effective anti-biofilm strategies require a deeper understanding of resistance mechanisms and improved in vitro models.
• Current therapies have limitations, necessitating the development of novel approaches.
• Future research should focus on innovative treatments to combat persistent biofilm infections.